目的:构建MAGE-1(melanoma antigen 1)与人HSP70(heat shock protein70)融合基因的真核表达载体pCDNA3.1-MAGE-1-HSP70,为肿瘤DNA疫苗研究奠定基础。方法:利用PCR方法扩增人HSP70基因,经测序后连入真核表达载体pCDNA3.1,再通过PCR方法扩增MAGE-1基因,测序后插入HSP70基因的5’端,构建了MAGE-1与人HSPTO融合基因表达载体pCDNA3.1-MAGE-1-HSP70。结果:成功地扩增了人HSP70基因与MAGE-1基因,测序结果表明与GenBank公布的序列一致,成功地构建了pCDNA3.1-MAGE-1-HSP70真核表达载体。结论:成功地构建MAGE-1与人HSP70融合基因的真核表达载体pCDNA3.1-MAGE-1-HSP70,为进一步DNA肿瘤疫苗研究提供了实验基础。
Objective:To construct the MAGE - 1 and human HSP70 fusion gene eukaryotic expression vector Methods :The HSP70 and MAGE - 1 genes were amplified by PCR. After sequencing, the two genes were cloned into the eukaryotic expression vector pCDNA3.1 to construct fusion gene expression plasmid pCDNA3.1 - MAGE - 1 - HSP70. Results:The HSP70 gene and MAGE - 1 gene were amplified successfully from plasmids, and their sequences were identical with that reported in GenBank. The fusion gene expression plasmid pCDNA3.1 - MAGE - 1 - HSP70 was successfully constructed. Conclusion :The MAGE -1 and Hsp70 fusion gene eukaryotic expression vector pCDNA3.1 - MAGE - 1 - HSP70 was constructed, which prepared the materials for the research of DNA vaccine.